← Eichor
Study identifier: NCT05288790 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

Condition: Microtia · Dysbiosis · Alcohol Drinking  ·  Sponsor: Vanderbilt University Medical Center

PhasePhase 2
Planned participants250
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersNo

About this study

Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.

This description comes directly from the study's public registry record.

Talk to the study team

Grace Wallace, BS  ·  615-936-5356  ·  grace.wallace@vumc.org

Emily Smith, MPH  ·  6158757253  ·  emily.k.smith@vumc.org

Always discuss trial participation with your own doctor first.

Locations (1)

Vanderbilt University Medical CenterNashville, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05288790